Acer Therapeutics Inc. Note Agreements

9 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to Unsecured Promissory Note between Acer Therapeutics Inc. and Christopher Schelling
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Unsecured Promissory Note between Acer Therapeutics Inc. and Christopher Schelling dated June 22, 2023
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2023
Acer Therapeutics Inc. Secured Convertible Note Agreement with MAM Aardvark, LLC/Marathon Healthcare Finance Fund, L.P.
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2022
Opexa Therapeutics, Inc. 12% Convertible Secured Promissory Note (July 25, 2012)
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
TX
2012
Note Purchase Agreement between Opexa Therapeutics, Inc. and Investors (July 25, 2012)
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
TX
2012
Opexa Therapeutics, Inc. 10% Convertible Promissory Note Agreement (April 2009)
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
2009
Acer Therapeutics Inc. Secured Convertible Note Purchase and Security Agreement with MAM Aardvark, LLC and Purchasers (March 2022)
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
DE
2022
Promissory Note between Acer Therapeutics Inc. and Relief Therapeutics Holding AG dated January 25, 2021
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
NY
2021
Opexa Therapeutics, Inc. 12% Convertible Promissory Note Agreement (January 23, 2013)
Note Agreements
Acer Therapeutics Inc.
Pharmaceuticals
TX
2013